TIGAR and esophageal squamous cell carcinoma: Compared to ESCC-PDXs with low TIGAR expression, those with TIGAR overexpression were more resistant to 5-fluorouracil/Cisplatin, whereas they were sensitized by a glutaminase inhibitor, CB-839 [51].